Copyright Reports & Markets. All rights reserved.

Global Virus-like Particle Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Virus-like Particle Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 E. coli
    • 1.3.3 Yeast
    • 1.3.4 Insect Cells
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Virus-like Particle Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Vaccine
    • 1.4.3 Therapeutics
    • 1.4.4 Bioimaging
    • 1.4.5 Others
  • 1.5 Global Virus-like Particle Market Size & Forecast
    • 1.5.1 Global Virus-like Particle Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Virus-like Particle Sales Quantity (2021-2032)
    • 1.5.3 Global Virus-like Particle Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 The Native Antigen Company
    • 2.1.1 The Native Antigen Company Details
    • 2.1.2 The Native Antigen Company Major Business
    • 2.1.3 The Native Antigen Company Virus-like Particle Product and Services
    • 2.1.4 The Native Antigen Company Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 The Native Antigen Company Recent Developments/Updates
  • 2.2 Creative BioStructure
    • 2.2.1 Creative BioStructure Details
    • 2.2.2 Creative BioStructure Major Business
    • 2.2.3 Creative BioStructure Virus-like Particle Product and Services
    • 2.2.4 Creative BioStructure Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Creative BioStructure Recent Developments/Updates
  • 2.3 Creative Biolabs
    • 2.3.1 Creative Biolabs Details
    • 2.3.2 Creative Biolabs Major Business
    • 2.3.3 Creative Biolabs Virus-like Particle Product and Services
    • 2.3.4 Creative Biolabs Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Creative Biolabs Recent Developments/Updates
  • 2.4 Leadgene Biomedical
    • 2.4.1 Leadgene Biomedical Details
    • 2.4.2 Leadgene Biomedical Major Business
    • 2.4.3 Leadgene Biomedical Virus-like Particle Product and Services
    • 2.4.4 Leadgene Biomedical Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Leadgene Biomedical Recent Developments/Updates
  • 2.5 Abcam
    • 2.5.1 Abcam Details
    • 2.5.2 Abcam Major Business
    • 2.5.3 Abcam Virus-like Particle Product and Services
    • 2.5.4 Abcam Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abcam Recent Developments/Updates
  • 2.6 ACROBiosystems
    • 2.6.1 ACROBiosystems Details
    • 2.6.2 ACROBiosystems Major Business
    • 2.6.3 ACROBiosystems Virus-like Particle Product and Services
    • 2.6.4 ACROBiosystems Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 ACROBiosystems Recent Developments/Updates
  • 2.7 Gentarget
    • 2.7.1 Gentarget Details
    • 2.7.2 Gentarget Major Business
    • 2.7.3 Gentarget Virus-like Particle Product and Services
    • 2.7.4 Gentarget Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Gentarget Recent Developments/Updates
  • 2.8 VectorBuilder
    • 2.8.1 VectorBuilder Details
    • 2.8.2 VectorBuilder Major Business
    • 2.8.3 VectorBuilder Virus-like Particle Product and Services
    • 2.8.4 VectorBuilder Virus-like Particle Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 VectorBuilder Recent Developments/Updates

3 Competitive Environment: Virus-like Particle by Manufacturer

  • 3.1 Global Virus-like Particle Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Virus-like Particle Revenue by Manufacturer (2021-2026)
  • 3.3 Global Virus-like Particle Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Virus-like Particle by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Virus-like Particle Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Virus-like Particle Manufacturer Market Share in 2025
  • 3.5 Virus-like Particle Market: Overall Company Footprint Analysis
    • 3.5.1 Virus-like Particle Market: Region Footprint
    • 3.5.2 Virus-like Particle Market: Company Product Type Footprint
    • 3.5.3 Virus-like Particle Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Virus-like Particle Market Size by Region
    • 4.1.1 Global Virus-like Particle Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Virus-like Particle Consumption Value by Region (2021-2032)
    • 4.1.3 Global Virus-like Particle Average Price by Region (2021-2032)
  • 4.2 North America Virus-like Particle Consumption Value (2021-2032)
  • 4.3 Europe Virus-like Particle Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Virus-like Particle Consumption Value (2021-2032)
  • 4.5 South America Virus-like Particle Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Virus-like Particle Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Virus-like Particle Sales Quantity by Type (2021-2032)
  • 5.2 Global Virus-like Particle Consumption Value by Type (2021-2032)
  • 5.3 Global Virus-like Particle Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Virus-like Particle Sales Quantity by Application (2021-2032)
  • 6.2 Global Virus-like Particle Consumption Value by Application (2021-2032)
  • 6.3 Global Virus-like Particle Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Virus-like Particle Sales Quantity by Type (2021-2032)
  • 7.2 North America Virus-like Particle Sales Quantity by Application (2021-2032)
  • 7.3 North America Virus-like Particle Market Size by Country
    • 7.3.1 North America Virus-like Particle Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Virus-like Particle Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Virus-like Particle Sales Quantity by Type (2021-2032)
  • 8.2 Europe Virus-like Particle Sales Quantity by Application (2021-2032)
  • 8.3 Europe Virus-like Particle Market Size by Country
    • 8.3.1 Europe Virus-like Particle Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Virus-like Particle Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Virus-like Particle Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Virus-like Particle Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Virus-like Particle Market Size by Region
    • 9.3.1 Asia-Pacific Virus-like Particle Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Virus-like Particle Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Virus-like Particle Sales Quantity by Type (2021-2032)
  • 10.2 South America Virus-like Particle Sales Quantity by Application (2021-2032)
  • 10.3 South America Virus-like Particle Market Size by Country
    • 10.3.1 South America Virus-like Particle Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Virus-like Particle Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Virus-like Particle Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Virus-like Particle Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Virus-like Particle Market Size by Country
    • 11.3.1 Middle East & Africa Virus-like Particle Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Virus-like Particle Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Virus-like Particle Market Drivers
  • 12.2 Virus-like Particle Market Restraints
  • 12.3 Virus-like Particle Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Virus-like Particle and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Virus-like Particle
  • 13.3 Virus-like Particle Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Virus-like Particle Typical Distributors
  • 14.3 Virus-like Particle Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Virus-like Particle market size was valued at US$ 423 million in 2025 and is forecast to a readjusted size of US$ 749 million by 2032 with a CAGR of 8.6% during review period.
    Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Virus-like Particle market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Virus-like Particle market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Virus-like Particle market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Virus-like Particle market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Virus-like Particle market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Virus-like Particle
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Virus-like Particle market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include The Native Antigen Company, Creative BioStructure, Creative Biolabs, Leadgene Biomedical, Abcam, ACROBiosystems, Gentarget, VectorBuilder, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Virus-like Particle market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    E. coli
    Yeast
    Insect Cells
    Others
    Market segment by Application
    Vaccine
    Therapeutics
    Bioimaging
    Others
    Major players covered
    The Native Antigen Company
    Creative BioStructure
    Creative Biolabs
    Leadgene Biomedical
    Abcam
    ACROBiosystems
    Gentarget
    VectorBuilder
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Virus-like Particle product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Virus-like Particle, with price, sales quantity, revenue, and global market share of Virus-like Particle from 2021 to 2026.
    Chapter 3, the Virus-like Particle competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Virus-like Particle breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Virus-like Particle market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Virus-like Particle.
    Chapter 14 and 15, to describe Virus-like Particle sales channel, distributors, customers, research findings and conclusion.

    Buy now